{
  "meta": {
    "data_length": 1,
    "message": "Therapy group id txgrp:106 retrieved successfully",
    "request_url": "https://api.moalmanac.org/therapy_groups?therapy_group_id=txgrp%3A106",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.00206,
    "timestamp_received": "2026-10-16T23:38:56.296871+00:00Z",
    "timestamp_returned": "2026-10-16T23:38:56.298931+00:00Z",
    "trace_id": "b18be666-29fe-4fcd-9b0e-b59b64b86ee3"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://moalmanac.org",
    "last_updated": "2026-08-02"
  },
  "data": [
    {
      "id": "txgrp:106",
      "membershipOperator": "AND",
      "therapies": [
        {
          "id": "tx:ncit:C2039",
          "conceptType": "Therapy",
          "name": "Bevacizumab",
          "mappings": [
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:rxcui:253337",
                "code": "253337",
                "name": "bevacizumab",
                "system": "RxNorm",
                "systemVersion": "20250602",
                "iris": [
                  "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=253337"
                ]
              }
            },
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:omop:1397141",
                "code": "1397141",
                "name": "bevacizumab",
                "system": "OMOP",
                "systemVersion": "v20250827",
                "iris": [
                  "https://athena.ohdsi.org/search-terms/terms/1397141"
                ]
              }
            }
          ],
          "extensions": [
            {
              "name": "therapy_strategy",
              "value": [
                "VEGF inhibition"
              ],
              "description": "Associated therapeutic strategy or mechanism of action of the therapy."
            },
            {
              "name": "therapy_type",
              "value": "Targeted therapy",
              "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
            }
          ],
          "primaryCoding": {
            "id": "coding:ncit:C2039",
            "code": "C2039",
            "name": "Bevacizumab",
            "system": "https://evsexplore.semantics.cancer.gov",
            "systemVersion": "26.08e",
            "iris": [
              "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2039"
            ]
          }
        },
        {
          "id": "tx:ncit:C65530",
          "conceptType": "Therapy",
          "name": "Erlotinib",
          "mappings": [
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:rxcui:337525",
                "code": "337525",
                "name": "erlotinib",
                "system": "RxNorm",
                "systemVersion": "20250602",
                "iris": [
                  "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=337525"
                ]
              }
            },
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:omop:1325363",
                "code": "1325363",
                "name": "erlotinib",
                "system": "OMOP",
                "systemVersion": "v20250827",
                "iris": [
                  "https://athena.ohdsi.org/search-terms/terms/1325363"
                ]
              }
            }
          ],
          "extensions": [
            {
              "name": "therapy_strategy",
              "value": [
                "EGFR inhibition"
              ],
              "description": "Associated therapeutic strategy or mechanism of action of the therapy."
            },
            {
              "name": "therapy_type",
              "value": "Targeted therapy",
              "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
            }
          ],
          "primaryCoding": {
            "id": "coding:ncit:C65530",
            "code": "C65530",
            "name": "Erlotinib",
            "system": "https://evsexplore.semantics.cancer.gov",
            "systemVersion": "26.08e",
            "iris": [
              "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C65530"
            ]
          }
        }
      ]
    }
  ]
}